Trisomy 21 activates the kynurenine pathway via increased dosage of interferon receptors.
Powers RK, Culp-Hill R, Ludwig MP, Smith KP, Waugh KA, Minter R, Tuttle KD, Lewis HC, Rachubinski AL, Granrath RE, Carmona-Iragui M, Wilkerson RB, Kahn DE, Joshi M, Lleó A, Blesa R, Fortea J, D'Alessandro A, Costello JC, Sullivan KD, Espinosa JM.
Powers RK, et al. Among authors: smith kp.
Nat Commun. 2019 Oct 18;10(1):4766. doi: 10.1038/s41467-019-12739-9.
Nat Commun. 2019.
PMID: 31628327
Free PMC article.